DCGI Grants Approval to MSD India’s Keytruda for Triple-Negative Breast Cancer Treatment
Hyderabad, Oct 25: MSD pharmaceutical (known as Merck in U.S. and Canada), on Wednesday announced that the Drug Controller General...
October 25, 2023
Hyderabad, Oct 25: MSD pharmaceutical (known as Merck in U.S. and Canada), on Wednesday announced that the Drug Controller General...